Bertram et al. observed doxorubicin resistance in S100P-expressing CRC cells (138), while S100P absence or knockdown inhibits CRC cell growth, migration and invasion in vitro, as well as tumor growth and liver metastasis in a xenograft nude mouse model in vivo (139, 140). The gene discussed is S100P; the disease is neoplasm.